14 results
S-8
EX-99.1
TAK
Takeda Pharmaceutical Co
25 Jun 20
Registration of securities for employees
6:21am
of the Award Recipient's employment (other than any such failure resulting from the Award Recipient's Disability) provided that any … Company Limited, a company registered in Japan.
"Companies Act" means the Companies Act of Japan (Act No. 86 of 2005), as amended.
"Disability" means
6-K
TAK
Takeda Pharmaceutical Co
11 Sep 23
Current report (foreign)
6:50am
arthritis, physician global assessment of psoriatic arthritis, patient pain scale, disability history questionnaire and an acute phase reactant.9
About
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
functional worsening, time to relapse, change from pre-subcutaneous treatment baseline in Rasch-built Overall Disability Scale (R-ODS) centile score … as maintenance therapy to prevent the relapse of neuromuscular disability and impairment in adult patients. The approval is based on results from ADVANCE
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
in Rasch-built Overall Disability Scale (R-ODS) centile score and safety. Results showed a clinically significant reduction in relapse rate with HYQVIA
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Apr 21
Current report (foreign)
6:29am
Disability 1. Trevathan E. Epilepsia. 1997 Dec;38(12):1283-8., 2. LGS Takeda Internal estimates/data on file Feb 2021., 3. Kim H.J. Epilepsy Research
6-K
hi1u0
30 Oct 23
Current report (foreign)
6:02am
6-K
EX-99.1
109xv7l071nk21o
8 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
jp46 3basmmd
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
9mefzzmvds121
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
EX-99.1
qpsl747vh982 npe
17 Dec 20
Current report (foreign)
6:01am
- Prev
- 1
- Next